Long noncoding RNA TTN-AS1 facilitates tumorigenesis and metastasis by maintaining TTN expression in skin cutaneous

Ying Wang1,2, Dongping Li1,2, Jiqiang Lu1,2

  • 1The Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing, 210009, China.

Cell Death & Disease
|August 22, 2020
PubMed

Insights

Long noncoding RNA TTN-AS1 promotes skin cutaneous melanoma (SKCM) by increasing titin (TTN) expression. High TTN-AS1 and TTN levels correlate with poor SKCM patient survival, suggesting potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Antisense transcripts play crucial roles in gene regulation.
  • Long noncoding RNAs (lncRNAs) are increasingly recognized for their involvement in various biological processes, including cancer.

Purpose of the Study:

  • To investigate the role of lncRNA-TTN-AS1 in skin cutaneous melanoma (SKCM).
  • To explore the molecular mechanisms by which lncRNA-TTN-AS1 influences SKCM progression.
  • To assess the clinical significance of lncRNA-TTN-AS1 and its correlation with titin (TTN) in SKCM.

Main Methods:

  • Correlation analysis of TTN and lncRNA-TTN-AS1 expression in SKCM cells.
  • In vitro and in vivo functional assays to assess the impact of TTN-AS1 and TTN on SKCM tumorigenesis and metastasis.
  • Investigation of the epigenetic regulation of lncRNA-TTN-AS1 expression (hypomethylation).
  • Analysis of TTN promoter activity and TTN mRNA stability.
  • Clinical correlation analysis with patient survival data.

Main Results:

  • A significant positive correlation was observed between TTN and lncRNA-TTN-AS1 expression in SKCM.
  • Ectopic expression of TTN-AS1 and TTN promoted SKCM tumorigenesis and metastasis.
  • Knockdown of TTN partially reversed the pro-tumorigenic effects of lncRNA-TTN-AS1.
  • High expression of lncRNA-TTN-AS1 was linked to hypomethylation of its transcription initiation site.
  • LncRNA-TTN-AS1 enhanced TTN expression transcriptionally and post-transcriptionally by increasing TTN promoter activity and TTN mRNA stability.
  • High TTN and lncRNA-TTN-AS1 expression correlated with poor overall survival in SKCM patients.

Conclusions:

  • LncRNA-TTN-AS1 promotes SKCM progression by upregulating TTN expression via epigenetic modifications and mRNA stabilization.
  • LncRNA-TTN-AS1 and TTN represent potential novel biomarkers and therapeutic targets for SKCM.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K